-+ 0.00%
-+ 0.00%
-+ 0.00%

Denali Therapeutics Reports Positive Phase 1/2 Results for Tividenofusp Alfa in Hunter Syndrome

Reuters·12/30/2025 13:00:24

Please log in to view news